Literature DB >> 30546589

Atretic aortic coarctation in a 32-year-old woman diagnosed after her third pregnancy, treated percutaneously using a covered stent.

Iyad Al-Ammouri1, Fares Ayoub2, Tareq Goussous3.   

Abstract

Atretic aortic coarctation is a severe form of coarctation of aorta, where there is loss of luminal communication at the site of aortic isthmus. We present a case of a 32-year-old woman who had long-standing, treatment-resistant hypertension. She had three pregnancies. The third pregnancy ended in premature labor of a newborn female infant who was found to have severe coarctation of aorta. This diagnosis in the newborn child prompted proper evaluation of the mother, who was found to have atretic coarctation. The woman was treated successfully using a covered Advanta V12 stent (Atrium, Hudson, NH, USA), after percutaneous needle puncture of the atretic isthmus. Anatomical orientation of the aorta at the site of coarctation and its relationship to the safety of needle puncture approach are discussed. This case brings an old lesson to the table, where proper evaluation of severe, treatment-resistant hypertension in adults should include screening for secondary causes. <Learning objective: Evaluation of severe and resistant systemic hypertension in adults should include screening for aortic coarctation. Pregnancy in women with coarctation of aorta carries significant risk to both the woman and the fetus. Atretic coarctation is a severe form of coarctation where there is complete obstruction of aortic isthmus. This can be treated successfully by percutaneous approach using covered stents.>.

Entities:  

Keywords:  Adult coarctation; Aortic isthmus atresia; Coarctation stenting

Year:  2015        PMID: 30546589      PMCID: PMC6281897          DOI: 10.1016/j.jccase.2015.07.009

Source DB:  PubMed          Journal:  J Cardiol Cases        ISSN: 1878-5409


  10 in total

1.  [A case of an unusual type of coarctation of the aorta terminating in the complete obstruction].

Authors:  A Furihata; Y Sasaki; Y Furihata; S Koike; S Takayama; S Furuta
Journal:  Kokyu To Junkan       Date:  1992-11

2.  Stent angioplasty in aortic arch interruption.

Authors:  G Santoro; M G Russo; R Calabrò
Journal:  Heart       Date:  2006-11       Impact factor: 5.994

3.  Infolding of covered stents used for aortic coarctation: report of two cases.

Authors:  Andrea W Wan; Kyong-Jin Lee; Lee N Benson
Journal:  Catheter Cardiovasc Interv       Date:  2013-07-05       Impact factor: 2.692

Review 4.  Interrupted aortic arch or extreme coarctation? A case report and review of the literature.

Authors:  Onder Teskin; A Umit Gullu; Sahin Senay; E Murat Okten; Cem Alhan
Journal:  Heart Surg Forum       Date:  2011-06       Impact factor: 0.676

5.  Percutaneous treatment of aortic isthmus atresia: use of radiofrequency perforation and covered stents.

Authors:  Gianfranco Butera; Mohamed Heles; Mario Carminati
Journal:  Catheter Cardiovasc Interv       Date:  2011-08-08       Impact factor: 2.692

6.  Coarctation of the aorta: outcome of pregnancy.

Authors:  L M Beauchesne; H M Connolly; N M Ammash; C A Warnes
Journal:  J Am Coll Cardiol       Date:  2001-11-15       Impact factor: 24.094

7.  Covered Cheatham-platinum stents for aortic coarctation: early and intermediate-term results.

Authors:  Aphrodite Tzifa; Peter Ewert; Grazyna Brzezinska-Rajszys; Bjoern Peters; Maria Zubrzycka; Eric Rosenthal; Felix Berger; Shakeel A Qureshi
Journal:  J Am Coll Cardiol       Date:  2006-03-20       Impact factor: 24.094

8.  Treatment of aortic isthmus atresia with a covered stent.

Authors:  Andreas Eicken; H Kaemmerer; Peter Ewert
Journal:  Catheter Cardiovasc Interv       Date:  2008-11-15       Impact factor: 2.692

Review 9.  The incidence of congenital heart disease.

Authors:  Julien I E Hoffman; Samuel Kaplan
Journal:  J Am Coll Cardiol       Date:  2002-06-19       Impact factor: 24.094

10.  Experience with the Atrium Advanta covered stent for aortic obstruction.

Authors:  Naoki Ohno; Rajiv Chaturvedi; Kyong-Jin Lee; Eric M Horlick; Mark D Osten; Lee N Benson
Journal:  J Interv Cardiol       Date:  2013-08       Impact factor: 2.279

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.